Robert M.A. Thwaites

Cost-effectiveness of salmeterol/fluticasone propionate combination product 50/250 μ g twice daily and budesonide 800 μ g twice daily in the treatment of adults and adolescents with asthma

Bo Lundbäck, Christine Jenkins, Martin Price et al. · Respiratory Medicine · 2000 · 45 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +12

The cost-effectiveness of inhaled fluticasone propionate and budesonide in the treatment of asthma in adults and children

Neil Barnes, Robert M.A. Thwaites, Martin Price · Respiratory Medicine · 1999 · 32 citations · Full text

Pharmacy, Pediatrics, Pharmacoeconomics +12

Cost-Effectiveness Analysis of Salmeterol/Fluticasone Propionate 50/500??g vs Fluticasone Propionate 500??g in Patients with Corticosteroid-Dependent Asthma V: Results

Willem R. Pieters, Bo Lundb ck, Seema Sondhi et al. · PharmacoEconomics · 1999 · 26 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Cost-Effectiveness Analyses of Salmeterol/Fluticasone Propionate Combination Product and Fluticasone Propionate in Patients with Asthma II: Study Methodologies

Willem R. Pieters, Bo Lundb ck, Gunnar Johansson et al. · PharmacoEconomics · 1999 · 18 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +11

Cost-Effectiveness Analyses of Salmeterol/Fluticasone Propionate Combination Product and Fluticasone Propionate in Patients with Asthma I: Introduction and Overview

Bo Lundbäck, Willem R. Pieters, Gunnar Johansson et al. · PharmacoEconomics · 1999 · 17 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +11